| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |